These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 18181527)

  • 1. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits.
    Attia IA; El-Gizawy SA; Fouda MA; Donia AM
    AAPS PharmSciTech; 2007 Dec; 8(4):E106. PubMed ID: 18181527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
    Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
    Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of niosomes containing ribavirin for liver targeting.
    Hashim F; El-Ridy M; Nasr M; Abdallah Y
    Drug Deliv; 2010 Jul; 17(5):282-7. PubMed ID: 20350052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
    Guinedi AS; Mortada ND; Mansour S; Hathout RM
    Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced oral bioavailability of griseofulvin via niosomes.
    Jadon PS; Gajbhiye V; Jadon RS; Gajbhiye KR; Ganesh N
    AAPS PharmSciTech; 2009; 10(4):1186-92. PubMed ID: 19856107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of formulation compositions on niosomal preparations.
    Chaw CS; Kim KY
    Pharm Dev Technol; 2013; 18(3):667-72. PubMed ID: 22468904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonpolymeric nanoassemblies for ocular administration of acyclovir: pharmacokinetic evaluation in rabbits.
    Stella B; Arpicco S; Rocco F; Burgalassi S; Nicosia N; Tampucci S; Chetoni P; Cattel L
    Eur J Pharm Biopharm; 2012 Jan; 80(1):39-45. PubMed ID: 22008147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and development of microemulsion drug delivery system of acyclovir for improvement of oral bioavailability.
    Ghosh PK; Majithiya RJ; Umrethia ML; Murthy RS
    AAPS PharmSciTech; 2006 Sep; 7(3):77. PubMed ID: 17025257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and development of multiple emulsion for enhancement of oral bioavailability of acyclovir.
    Paul S; Kumar A; Yedurkar P; Sawant K
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1809-17. PubMed ID: 23281917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug.
    Rasul A; Imran Khan M; Ur Rehman M; Abbas G; Aslam N; Ahmad S; Abbas K; Akhtar Shah P; Iqbal M; Ahmed Al Subari AM; Shaheer T; Shah S
    Int J Nanomedicine; 2020; 15():7937-7949. PubMed ID: 33116510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual fast dissolving niosomal films for enhanced bioavailability and prolonged effect of metoprolol tartrate.
    Allam A; Fetih G
    Drug Des Devel Ther; 2016; 10():2421-33. PubMed ID: 27536063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement.
    Kamboj S; Saini V; Bala S
    ScientificWorldJournal; 2014; 2014():959741. PubMed ID: 24672401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained release of acyclovir from nano-liposomes and nano-niosomes: an in vitro study.
    Mukherjee B; Patra B; Layek B; Mukherjee A
    Int J Nanomedicine; 2007; 2(2):213-25. PubMed ID: 17722549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroretentive drug delivery system of acyclovir-loaded alginate mucoadhesive microspheres: formulation and evaluation.
    Shadab ; Ahuja A; Khar RK; Baboota S; Chuttani K; Mishra AK; Ali J
    Drug Deliv; 2011 May; 18(4):255-64. PubMed ID: 21110695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorbitan ester niosomes for topical delivery of rofecoxib.
    Das MK; Palei NN
    Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of a novel gastric mucoadhesive sustained-release acyclovir microsphere.
    Liu H; Pan W; Ke P; Dong Y; Ji L
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1098-105. PubMed ID: 20545521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid.
    Lin T; Fang Q; Peng D; Huang X; Zhu T; Luo Q; Zhou K; Chen W
    Drug Deliv; 2013; 20(7):277-84. PubMed ID: 24044645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced ocular bioavailability of fluconazole from niosomal gels and microemulsions: formulation, optimization, and in vitro-in vivo evaluation.
    Soliman OAE; Mohamed EA; Khatera NAA
    Pharm Dev Technol; 2019 Jan; 24(1):48-62. PubMed ID: 29210317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
    Abdelbary AA; AbouGhaly MH
    Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits.
    Jain N; Verma A; Jain N
    Drug Deliv; 2020 Dec; 27(1):888-899. PubMed ID: 32551978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.